Drug · DIN 02237000
REACTINE EYE DROPS
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since January 27, 2026.
- Drug Identification Number (DIN)
- 02237000
- Company (DIN owner)
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Drops
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Naphazoline, combinations S01GA51
- Class
- Human
- Record last updated
- February 3, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PHENIRAMINE MALEATE | 0.3 % | W/V |
| NAPHAZOLINE HYDROCHLORIDE | 0.025 % | W/V |